CytomX (CTMX) 2025 Earnings Outlook for Investors Worldwide
CytomX sits at a crossroads as 2025 earnings unfold, with pipeline updates, collaboration deals, and cost discipline ...
Using index funds with active funds works best in markets with clear diversification needs and where costs and risk management matter most.
21,614 articlesCytomX sits at a crossroads as 2025 earnings unfold, with pipeline updates, collaboration deals, and cost discipline ...
Tether unveils a Visa-enabled card tied to tokenized gold, offering XAUT rewards. The roll-out signals growing mainst...
Investors are eyeing Lilly for its resilient growth, strong pipeline, and shareholder-friendly strategy. This piece b...
OpenAI's finance chief says AI-tool fluency is now a baseline for finance hires, with Codex playing a key role as dem...
Insiders sold a meaningful block of stock at Select Water Solutions, yet the company still shows a strong growth stor...
When Beyond Meat posted its latest results, a sharp selloff followed. This article dissects why investors bailed beyo...
Red light therapy is moving from luxury spas to home devices and clinics. This report breaks down the costs, the scie...
Two travel giants—Vail Resorts and Viking Holdings—represent different bets on leisure demand. This analysis compares...
SpaceX begins trading on Nasdaq under SPCX, aiming to redefine public markets for space technology. Investors weigh s...
When a veteran value investor piles into a beaten-down name, traders take notice. Prem Watsa recently added to his Un...
A practical comparison of Corning and QuantumScape for 2026. Learn where each stock shines, the risks you should watc...
A routine auto theft can spiral into a cross-state investigation. This article breaks down what happened, the financi...